Currently the Physician-in-Chief and Distinguished Professor for Translational Research Division at TGen.
He is also Chief Scientific Officer for Scottsdale Healthcare’s Clinical Research Institute; and Medical Director of Research at McKesson Specialty Health, and Scientific Medical Officer for US Oncology Research.
He holds an appointment as Professor of Medicine, Mayo Clinic, Scottsdale, AZ.
Dr. Von Hoff has been involved in developing many new anticancer drugs, and has published extensively.
He was appointed to President Bush’s National Cancer Advisory Board from 2004 – 2010, and was the recipient of the 2010 David A. Karnosky Award from the American Society of Clinical Oncology.
Keith Chan, Ph.D
Dr. Chan is Senior Advisor at Cornerstone Intellectual Property Foundation in Taiwan, and President of GloboAsia LLC in USA.
He is also adjunct professor of National Chengchi University and National Yang Ming University, visiting professor of National Taiwan University, and adjunct research fellow of Beijing University.
Dr. Chan is a well-known pharmaceutical scientist and business entrepreneur, has a wide range of business, managerial, regulatory and scientific experience.
His experience in new drug development including pre-clinical animal studies, bioanalytical method development, all phases of clinical studies and regulatory submission.
His latest accomplishment is leading an Asian pharmaceutical company to complete a new drug development program from start to worldwide market approval. The new drug is now approved and launched in Japan, US, Taiwan and more approvals are expecting.